ADVATE (Baxalta US Inc.)
Welcome to the PulseAid listing for the ADVATE drug offered from Baxalta US Inc.. This pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
LABELER NAME / MANUFACTURER: | Baxalta US Inc. |
NON-PROPRIETARY NAME: | Antihemophilic Factor, Human Recombinant |
SUBSTANCE NAME: | |
TYPE: | PLASMA DERIVATIVE |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2014-06-25 |
END MARKETING DATE: | 0000-00-00 |
ADVATE PLASMA DERIVATIVE Details:
Item Description | ADVATE from Baxalta US Inc. |
LABELER NAME: | Baxalta US Inc. |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2014-06-25 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0944-3045_e2c14c93-1992-4615-b3b0-8bd176823158 |
PRODUCT NDC: | 0944-3045 |
APPLICATION NUMBER: | BLA125063 |